A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study
Author(s) -
Sophia Airhart,
W. Todd Cade,
Hui Jiang,
Andrew R. Coggan,
Susan B. Racette,
Kevin Korenblat,
Catherine Anderson Spearie,
Suzanne Waller,
Robert O’Connor,
Adil Bashir,
Daniel S. Ory,
Jean E. Schaffer,
Eric Novak,
Marsha Farmer,
Alan D. Waggoner,
Víctor G. DávilaRomán,
Cylen Javidan-Nejad,
Linda R. Peterson
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-3292
Subject(s) - type 2 diabetes , diabetes mellitus , medicine , cardiology , endocrinology , food science , chemistry
Excessive cardiac long-chain fatty acid (LCFA) metabolism/storage causes cardiomyopathy in animal models of type 2 diabetes. Medium-chain fatty acids (MCFAs) are absorbed and oxidized efficiently. Data in animal models of diabetes suggest MCFAs may benefit the heart.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom